Showing results (201-210 of 317) with videos related to

Sort By:
Pageof 32
Medical Physics|February 5, 2019
Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MRDiem Vuong, Stephanie Tanadini-Lang, Martin W Huellner, et al.
The British Journal of Radiology|May 30, 2008
Whole-body PET/CT-mammography for staging breast cancer: initial resultsT-A Heusner, L S Freudenberg, H Kuehl, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|October 27, 2007
Cervical lymph node metastases of unknown origin: primary tumor detection with whole-body positron emission tomography/computed tomographyK Nassenstein, P Veit-Haibach, H Stergar, et al.
Tomography (Ann Arbor, Mich.)|September 27, 2024
<sup>18</sup>F-Fluoroazomycin Arabinoside (FAZA) PET/MR as a Biomarker of Hypoxia in Rectal Cancer: A Pilot StudyUr Metser, Andres Kohan, Catherine O'Brien, et al.
Radiology|September 16, 2017
Reduction of <sup>18</sup>F-FDG Dose in Clinical PET/MR Imaging by Using Silicon Photomultiplier DetectorsTetsuro Sekine, Gaspar Delso, Konstantinos G Zeimpekis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2014
Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?Felix P Kuhn, Martin Hüllner, Caecilia E Mader, et al.
Stem Cells (Dayton, Ohio)|October 21, 2015
Mesenchymal Stromal Cells Disrupt mTOR-Signaling and Aerobic Glycolysis During T-Cell ActivationMartin Böttcher, Andreas D Hofmann, Heiko Bruns, et al.
ACS Catalysis|April 17, 2023
Cu-Catalyzed C-N Coupling with Sterically Hindered PartnersAtanu Modak, Alex J Nett, Elizabeth C Swift, et al.
Inorganic Chemistry|October 24, 2001
Molecular Engineering of Photosensitizers for Nanocrystalline Solar Cells: Synthesis and Characterization of Ru Dyes Based on Phosphonated TerpyridinesS. M. Zakeeruddin, M. K. Nazeeruddin, P. Pechy, et al.
Scientific Reports|November 11, 2025
Added prognostic value of baseline pre-infusion <sup>18</sup>F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapySeyed Ali Mirshahvalad, Andres Kohan, Roshini Kulanthaivelu, et al.
Pageof 32